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Abstract
Several factors have been identified to affect morbidity and mortality in oral cancer patients. The time taken to
process a resected cancer specimen in a patient presenting with primary or recurrent disease can be of interest as
delay can affect earlier interventions post-surgery. We looked at this variable in a group of 168 consecutive oral
cancer patients and assessed its relationship to mortality from the disease at 3 and 5 years. It is expected that delay
in pathological processing time of surgical specimens acquired from patients with recurrent disease may increase or
contribute to the increased rate of mortality. Further high evidence-based studies are required to confirm this.
Introduction
The incidence of oral squamous cell carcinoma (OSCC)
remains high. Oral and oro-pharyngeal carcinomas are
the sixth most common cancer in the world. Numerous
clinicopathological parameters have been implicated in
prognosis, recurrence and survival, following this unfor-
giving disease [1,2].
The correct identification of pathology is essential to
the correct treatment. Unfortunately due to the nature of
replicative diseases, as in malignancy, tumour doubling
time becomes an issue. Even small delays in applying fur-
ther interventions may allow further tumour invasion
and infiltration of the loco-regional surroundings resulting
in a previously resectable growth becoming unresectable
or unmanageable with the current chemo-radiotherapeutic
protocols [1,2].
Pathological processing time is identified as the time
taken from acquiring the resected tumour specimen by
the surgeon to the reporting of the results by the histo-
pathologist. The report will usually include grading and
pathological staging of the tumour, the state of the surgi-
cal margins and any invasion to neurovascular or hard
tissue structures.
It has been known that histopathological processing
can take few days but this might increase if it involves
composite specimen (i.e. hard tissue). Also the use of
special testing can increase the time of processing. Over
the last few years an increase in the workload on path-
ology departments has lead to further delay in patho-
logical processing time [1].
The overall effects of delays in pathological processing
time are unknown. In this short communication, we
reviewed time intervals between taking the surgical spe-
cimen and definitive pathology report in patients with
primary or recurrent disease. In each case we correlated
this to 3- and 5-year survival rates.
Materials and methods
This retrospective analytic study looked at 168 consecu-
tive oral cancer patients who presented to University
College London Hospital over a 10-year period (1992–
2002). All patients suffered from recurrent disease. Pro-
formas were created to collect the clinicopathological
data and validated by a sample review.
Pathological processing time of the resected specimen
was identified. “Duration 1” refers to the time (in days)
taken to process and report on the resected tissue of the
primary tumour. While “Duration 2” refers to the time
(in days) taken to process and report on the resected tis-
sue of the recurrent disease.
Statistical analysis
The outcomes of the categorical clinicopathological vari-
ables were summarised as frequencies and percentages
for the whole group of patients and for the recurrence
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Figure 1 Pathological processing time of the resected specimens. “Duration 1” refers to the time (in days) taken to process and report on the
resected tissue of the primary tumour. While “Duration 2” refers to the time (in days) taken to process and report on the resected tissue of the
recurrent disease.
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death.
The duration of the pathological processing time of pri-
mary and recurrent disease was reported as means, stan-
dard deviations, minimal and maximal values. P-values
at 3 and 5 years were generated when comparing patho-
logical processing time in those who died from oral cancer
















Duration 1 13 6.5 4 29 0.839 0.035
Duration 2 17 8.9 3 40 0.039 0.033Results
The patient population comprised 113 males and 55
females; with 56.5 % Caucasians, 11.9 % Indians, 8.9 %
Middle-Easterns, 6.5 % Africans and 7.7 % Caribbean
backgrounds. Their mean age at the 1st diagnosis of OSCC
was 63.2 (SD4.6 years, Min 25 years, Max 94 years).
Primary sites were mainly identified in the tongue (50 %),
floor of mouth (25 %), buccal mucosa (8 %) and alveolus
(4 %). Tumour staging showed that half of the group had
T1/T2 N0M0 disease while the other half had T3/T4
N0M0 disease. Treatment involved surgery alone in 12
patients, surgery and radiotherapy in 71 patients, surgery
and radiochemotherapy in 26 patients, while the rest of the
group received radiotherapy, chemotherapy, laser surgery or
photodynamic therapy as the sole treatment at that time.
Overall survival at 3 years was 63.7 %. 71/113 males
survived after 3 years from diagnosis compared to 36/55
females. Survival at 5-years (48.8 %) showed 53/113 alive
males and 29/55 alive females. Cancer-related death
showed 31 males died from loco-regional cancer spread
and 15 who died from distant metastasis (i.e. pulmonary,
hepatic), while 12 females died from loco-regional causes
and 7 from distant cancer spread. Nearly all the patientswho succumbed to the disease were from Caucasian and
Indian backgrounds.
The mean pathological processing time of specimens
acquired from primary-diseased patients (Duration 1) was
reported as 13 days (SD6.5 days, Min 4 days, Max 29 days).
The mean pathological processing time of specimens
acquired from recurrent-diseased patients (Duration 2)
was reported as 17 days (SD8.9 days, Min 3 days, Max
40 days). The 40-day duration has been seen in all patients
who have had hard tissue resection. Figure 1 highlights
the pathological processing time.
No significant relationship was identified between Du-
ration 1 (Pathological processing time of 1st SCC) and
mortality at 3 years (P=0.839) but there was a significant
relationship at 5 years (P=0.035), however this was clinic-
ally irrelevant (Table 1; Figures 2 and 3). For Duration 2
(pathological processing time of recurrent SCC), a signifi-
cant relationship was identified at 3 years (P=0.039) and
5 years (P=0.033), (Table 1, Figure 4 and 5).Discussion
Squamous cell carcinoma of the oral cavity has a poor
overall prognosis with a high tendency to recur at the
Figure 2 Duration 1 versus survival at 3 years. “Duration 1” refers to the time (in days) taken to process and report on the resected tissue of
the primary tumour.
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nodes. Several clinicopathological parameters can be
employed to assess outcome, recurrence and overall sur-
vival [1-3].
Despite evolution in management, the overall survival
of patients has not improved significantly during the pastFigure 3 Duration 1 versus survival at 5 years. “Duration 1” refers to the
the primary tumour.20 years, with 5-year survival rates between 45-50 %.
Prognosis depends or varies with tumour primary site,
nodal involvement, tumour thickness, and the status of
the surgical margins. Moreover, the cumulative effects of
tobacco, betel nut and alcohol decrease the survival rate
[1-3].time (in days) taken to process and report on the resected tissue of
Figure 4 Duration 2 versus survival at 3 years. “Duration 2” refers to the time (in days) taken to process and report on the resected tissue of
the recurrent disease.
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an important factor in cumulative prognosis but is espe-
cially significant in recurrent disease states. In recurrent
disease, the host tumour interface is already compro-
mised either as a consequence of the disease itself or itsFigure 5 Duration 2 versus survival at 5 years. “Duration 2” refers to the
the recurrent disease.attendant treatment; hence tumours tend to be more ag-
gressive in recurrence stage.
In patients with recurrent disease, previous interven-
tions may have already breached the host barriers allow-
ing tumour spread loco-regionally or not includedtime (in days) taken to process and report on the resected tissue of
suppressed tumour clones outside the original treatment
field. In these cases, time is of the essence and we would
commend meta-scheduling of the processing resected
tissue in patients who have already had previous tumour
treatment. However, it is worth highlighting the fact that
resection specimens of recurrence disease tend to be
more bulky as well as composite (i.e. include bone) in-
creasing the possibility of processing time.
It is, also, likely that confounding factors as in
immuno-suppression, tumour dedifferentiation, malnu-
trition, and treatment failure that would have lead to re-
currence and hence a poor prognosis in this subgroup.
In conclusion, pathological processing time might be
an important factor in oral cancer prognosis. It appears
that delay in tissue processing time in patients with re-
current disease may contribute to the increased mortality
rate. Further higher evidence-based studies are required
to prove this and to identify other parameters that could
influence morbidity and mortality when managing this
unforgiving disease.
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